期刊
HUMAN VACCINES
卷 5, 期 12, 页码 832-838出版社
LANDES BIOSCIENCE
DOI: 10.4161/hv.10297
关键词
public health; Francisella; tularemia; vaccine; bacteria; infection; biodefense
资金
- NIAID NIH HHS [U01 AI077909, U54 AI057168-02, U54 AI057168-07, U54 AI057168-06, U01 AI077909-02, U54 AI057168-03, U01 AI077909-01, U54 AI057168, U54 AI057168-01, U54 AI057168-05, U54 AI057168-08, U54 AI057168-04] Funding Source: Medline
Francisella tularensis is a Category A select agent for which vaccine and countermeasure development are a priority. In the past eight years, renewed interest in this pathogen has led to the generation of an enormous amount of new data on both the pathogen itself and its interaction with host cells. This information has fostered the development of various vaccine candidates including acellular subunit, killed whole cell and live attenuated. This review summarizes the progress and promise of these various candidates.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据